What adjustments should be made to insulin therapy and intravenous fluids when a patient with diabetic ketoacidosis (DKA) has a blood glucose level of 140mg/dl, specifically regarding the use of dextrose normal saline (DNS) and the rate of intravenous regular insulin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of DKA When Blood Glucose Reaches 140 mg/dL

When blood glucose falls to 140 mg/dL during DKA treatment, immediately add dextrose 5% to your IV fluids (switching to D5 with 0.45-0.75% NaCl) while continuing the insulin infusion at the current rate—never stop or reduce insulin until DKA is fully resolved. 1

Critical Action Steps at Glucose 140 mg/dL

Fluid Management

  • Switch from normal saline to 5% dextrose with 0.45-0.75% normal saline 1
  • The American Diabetes Association recommends adding dextrose when glucose falls below 200-250 mg/dL, so at 140 mg/dL you should already have dextrose running 1, 2
  • Continue potassium supplementation (20-30 mEq/L) in the dextrose solution to maintain serum K+ between 4-5 mmol/L 1, 3

Insulin Management

  • Continue IV regular insulin infusion at 0.1 units/kg/hour without reduction 1, 2
  • Target glucose between 150-200 mg/dL until complete DKA resolution 1, 3
  • The most common error causing persistent or worsening ketoacidosis is stopping or reducing insulin when glucose normalizes 1, 3

Why Continue Full-Dose Insulin Despite Low Glucose

  • Ketonemia takes substantially longer to clear than hyperglycemia 1, 3
  • DKA resolution requires ALL of the following: glucose <200 mg/dL **AND** serum bicarbonate ≥18 mEq/L **AND** venous pH >7.3 AND anion gap ≤12 mEq/L 1, 2, 3
  • Glucose normalization is only ONE criterion—you must continue insulin to clear ketones even with normal or low glucose 1, 3

Monitoring Requirements

  • Check blood glucose every 1-2 hours at this critical phase 2, 4
  • Measure serum electrolytes, venous pH, bicarbonate, and anion gap every 2-4 hours 1, 2, 3
  • Monitor serum potassium closely as insulin drives potassium intracellularly 2, 3
  • Follow β-hydroxybutyrate levels if available (preferred over urine ketones) 2, 4

Adjusting Dextrose Concentration

  • If glucose continues to fall below 150 mg/dL despite D5, consider increasing to 10% dextrose while maintaining insulin infusion 5, 6
  • In severe DKA cases, insulin rates of 4-6 U/hour or higher with 10-20% dextrose may be necessary to clear ketones while preventing hypoglycemia 5

When to Stop IV Insulin

  • Do NOT stop IV insulin until DKA is completely resolved: pH >7.3, bicarbonate ≥18 mEq/L, anion gap ≤12 mEq/L, and glucose <200 mg/dL 1, 2, 3
  • Administer basal subcutaneous insulin (glargine or detemir) 2-4 hours BEFORE stopping IV insulin 2, 3
  • Continue IV insulin for 1-2 hours after giving subcutaneous insulin to ensure adequate plasma levels and prevent DKA recurrence 1, 2, 3

Critical Pitfalls to Avoid

  • Never discontinue or reduce insulin infusion when glucose normalizes—this is the leading cause of persistent ketoacidosis 1, 3
  • Never stop IV insulin without prior basal insulin administration—this causes immediate DKA recurrence 2, 3
  • Failure to add dextrose when glucose falls below 250 mg/dL leads to hypoglycemia while trying to clear ketones 1, 3
  • Inadequate potassium monitoring during this phase can cause life-threatening hypokalemia as insulin drives K+ intracellularly 2, 3

Special Consideration: Euglycemic DKA

  • If this is euglycemic DKA (glucose <250 mg/dL at presentation), D5 should have been started from the beginning alongside insulin 1, 4
  • Continue the same management approach: insulin infusion with dextrose supplementation until metabolic acidosis resolves 4

References

Guideline

Resolving Diabetic Ketoacidosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diabetic Ketoacidosis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

First-Line Treatment for DKA in Type 1 Diabetes Mellitus

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Severe diabetic ketoacidosis: the need for large doses of insulin.

Diabetic medicine : a journal of the British Diabetic Association, 1999

Related Questions

What are the guidelines for managing diabetic ketoacidosis (DKA) with insulin therapy, including dosage and adjustment?
Is a 10% glucose solution indicated in the initial management of diabetic ketoacidosis?
When to initiate subcutaneous insulin in diabetic ketoacidosis?
What is the immediate treatment for a patient presenting with diabetes ketoacidosis (DKA)?
When to transition a 55-year-old female patient with diabetes ketoacidosis from insulin infusion to oral medications, with a current blood glucose level of hyperglycemia, and which oral medication group to use?
What is the best next step for a 34-week gestation patient with ruptured membranes for 6 hours, no contractions, a station of -1, no fever, vital stability, a fundal height of 30 weeks, and meconium-stained liquor?
Can hepatitis be transmitted through kissing in the presence of oral mucosa (mucous membrane) abrasions?
What causes a person to bite the inside of their mouth while eating?
What are the potential causes of an elevated Blood Urea Nitrogen (BUN) level with a stable Creatinine (Cr) level in a patient?
What are the considerations for switching an adult patient with schizophrenia, bipolar disorder, or major depressive disorder from cariprazine (partial dopamine D2 and D3 receptor agonist) 3 mg to aripiprazole (atypical antipsychotic) 2 mg?
What is the appropriate monitoring for a 14-year-old male with proteinuria, recent ear infection, and elevated Anti-Streptolysin O (ASO) titer, currently on amoxicillin, with normal creatinine (Cr) levels, elevated Complement 3 (C3) and Complement 4 (C4) levels, and elevated urine protein-to-creatinine (P:Cr) ratio?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.